Your browser doesn't support javascript.
loading
Itaconate promotes hepatocellular carcinoma progression by epigenetic induction of CD8+ T-cell exhaustion.
Gu, Xuemei; Wei, Haoran; Suo, Caixia; Shen, Shengqi; Zhu, Chuxu; Chen, Liang; Yan, Kai; Li, Zhikun; Bian, Zhenhua; Zhang, Pinggen; Yuan, Mengqiu; Yu, Yingxuan; Du, Jinzhi; Zhang, Huafeng; Sun, Linchong; Gao, Ping.
Afiliação
  • Gu X; School of Medicine, South China University of Technology, Guangzhou, China.
  • Wei H; Medical Research Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.
  • Suo C; Department of Colorectal Surgery, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, China.
  • Shen S; Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Zhu C; School of Medicine, South China University of Technology, Guangzhou, China.
  • Chen L; School of Medicine, South China University of Technology, Guangzhou, China.
  • Yan K; Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Li Z; School of Medicine, South China University of Technology, Guangzhou, China.
  • Bian Z; School of Medicine, South China University of Technology, Guangzhou, China.
  • Zhang P; The Chinese Academy of Sciences Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, China.
  • Yuan M; The Chinese Academy of Sciences Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, China.
  • Yu Y; School of Medicine, South China University of Technology, Guangzhou, China.
  • Du J; School of Medicine, South China University of Technology, Guangzhou, China.
  • Zhang H; The Chinese Academy of Sciences Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, China. hzhang22@ustc.edu.cn.
  • Sun L; Institute of Health and Medicine, Hefei Comprehensive National Science Center, Hefei, China. hzhang22@ustc.edu.cn.
  • Gao P; Medical Research Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China. sunlc@mail.ustc.edu.cn.
Nat Commun ; 14(1): 8154, 2023 Dec 09.
Article em En | MEDLINE | ID: mdl-38071226
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Limite: Humans Idioma: En Revista: Nat Commun Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Limite: Humans Idioma: En Revista: Nat Commun Ano de publicação: 2023 Tipo de documento: Article